| C02DB02 |
C02DB02 hydralazine |
| C02DB03 |
C02DB03 endralazine |
| C02DB04 |
C02DB04 cadralazine |
| C02DC |
C02DC Pyrimidine Derivatives |
| C02DC01 |
C02DC01 minoxidil |
| C02DD |
C02DD Nitroferricyanide derivatives |
| C02DD01 |
C02DD01 nitroprusside |
| C02DG |
C02DG Guanidine Derivatives |
| C02DG01 |
C02DG01 pinacidil |
| C02K |
C02K Other antihypertensives |
| C02KA |
C02KA Alkaloids, Excl. Rauwolfia |
| C02KA01 |
C02KA01 veratrum |
| C02KB |
C02KB Tyrosine Hydroxylase Inhibitors |
| C02KB01 |
C02KB01 metirosine |
| C02KC |
C02KC Mao Inhibitors |
| C02KC01 |
C02KC01 pargyline |
| C02KD |
C02KD Serotonin Antagonists |
| C02KD01 |
C02KD01 ketanserin |
| C02KX |
C02KX Antihypertensives for pulmonary arterial hypertension |
| C02KX01 |
C02KX01 Bosentan |
| C02KX02 |
C02KX02 Ambrisentan |
| C02KX03 |
C02KX03 Sitaxentan |
| C02KX04 |
C02KX04 Macitentan |
| C02KX05 |
C02KX05 Riociguat |
| C02KX06 |
C02KX06 Sotatercept |
| C02KX52 |
C02KX52 ambrisentan and tadalafil |
| C02KX54 |
C02KX54 Macitentan and tadalafil |
| C02L |
C02L Antihypertensives and diuretics in combination |
| C02LA |
C02LA Rauwolfia alkaloids and diuretics in combination |
| C02LA01 |
C02LA01 reserpine and diuretics |